Using Mx1-Cre;Bmpr1afx/fx mice, Zhang et al. found the HSC fraction (Linβ»Sca-1βΊc-KitβΊ) rose 2.0β2.4-fold and absolute HSCs per femur 1.5β2-fold despite a reduced marrow cavity; CRU limiting-dilution assays confirmed a 2.2-fold increase in functional LT-HSCs. Reciprocal Ly5.1/Ly5.2 transplantation localized the effect to the microenvironment: wild-type donor HSCs engrafted 1.6-fold better in mutant recipients, while mutant marrow performed normally in wild-type hosts .
Mechanistically, ectopic trabecular-bone-like areas (TBLA) formed where Bmpr1a was deleted (Z/EG-GFP tracing showed recombination restricted to the TBLA surface), lined by 2.3Γ more spindle-shaped N-cadherinβΊ osteoblastic (SNO) cells whose increase correlated with the 2.2-fold LT-HSC rise; BrdU-long-term-retaining LT-HSCs attached to SNO cells with asymmetric N-cadherin/Ξ²-catenin localization (same citation). The companion PTH/PPR paper independently showed osteoblast expansion raises HSC numbers via Notch (Linβ»Sca-1βΊc-KitβΊ: 32,500Β±8,000 β 65,700Β±7,500, p=0.008) .
Later work qualifies the model: N-cadherin knockout mice show no HSC defects, only ~20% of SLAM-defined HSCs sit at the endosteum versus ~60% contacting sinusoids, and ~97% localize to CXCL12-abundant reticular (CAR) cellsβsuggesting overlapping endosteal/vascular subcompartments rather than an SNO-only niche . Key limitations of the original study include PolyI:C-induced inflammation confounding hematopoiesis, regional Cre recombination, and correlational (not causal) TBLAβHSC linkage.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.